Market news
TypeAll
SortNewest
Assets
NERV
Sep 9Investing.com
NERV
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in two upcoming investor conferences. Wells Fargo Healthcare ConferenceDate: Tuesday, September 8Format: 1x1 meetingsLocation: New York, NY 2026 Cantor Global Healthcare ConferenceDate: Wednesday, September 9Format: Fireside cha
Aug 28Yahoo FinanceNERV
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Minerva Neurosciences (NERV) and Zymeworks (ZYME)
Detailed price information for Insmed Inc (INSM-Q) from The Globe and Mail including charting and trades.
Aug 7Yahoo FinanceNERV
This is the newest page. Registered accounts read further back.